Kalvista Pharmaceuticals Inc (KALV) Company Profile

Kalvista Pharmaceuticals Inc Company Snapshot

Kalvista Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kalvista Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Inhibrx Inc (2020 sales of $12.89 million of which 100% was Biologic therapeutic candidates), Kempharm Inc ($13.29 million of which 100% was Pharmaceutical company), and Ovid Therapeutics Inc ($12.62 million of which 100% was purposes of assessing performance).

Sales Analysis.

Kalvista Pharmaceuticals Inc

Stock Data:

Recent Stock Performance:

Current Price (4/16/2021): 24.45
(Figures in U.S. Dollars)

1 Week	-6.5%	13 Weeks	-24.5%

4 Weeks	40.6%	52 Weeks	120.1%

Kalvista Pharmaceuticals Inc Key Data:

Ticker:	KALV	Country:	United States

Exchanges:	NAS	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2020 Sales	12,690,000 (Year Ending Jan 2021).	Employees:	56

Currency:	U.S. Dollars	Market Cap:	440,618,927

Fiscal Yr Ends:	April	Shares Outstanding:	18,021,224

Share Type:	Common	Closely Held Shares:	1,653,645

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.